LiveCare Inc. (OTCMKTS

LVCE) Announces Stellar Revenue Growth, Strategic Patient Expansion in Telehealth for Diabetes Care, and Aspirations for NASDAQ Listing

Venice, FL, USA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), a leading telehealth company specializing in health coaching and comprehensive services for individuals with diabetes, is thrilled to announce significant achievements and future goals. The company has reported a current revenue of $3.3 million, with an ambitious projection of $12 million for the fiscal year 2024, showcasing an unparalleled growth trajectory in the telehealth sector.

LiveCare's innovative approach to diabetes management has been a key driver of its success, enrolling 50 new patients daily into its programs at a rate of $150 per month per patient. This rapid expansion is a clear indication of the high demand for specialized healthcare services that cater directly to the needs of those living with diabetes. Through personalized health coaching and tailored services, LiveCare is committed to improving the lives of its patients, ensuring better health outcomes and enhancing the quality of care.

Journey Towards Enhanced Transparency and Growth

In line with its financial growth and operational success, LiveCare is ambitiously pursuing the goal of becoming a fully reporting NASDAQ company. This strategic ambition reflects LiveCare's commitment to transparency, regulatory compliance, and the desire to broaden its impact in the healthcare industry. Transitioning from an OTC company to a NASDAQ-listed entity will enable LiveCare to attract a wider investor base, access greater capital opportunities, and further innovate in the telehealth space.

Future Focused on Innovation and Excellence in Diabetes Care

As LiveCare looks to the future, its focus remains steadfast on revolutionizing diabetes care through telehealth. By leveraging the latest in healthcare technology and maintaining a patient-first approach, LiveCare aims to set new standards in the industry, ensuring that individuals with diabetes receive the best possible care and support.

"We are incredibly proud of what we've accomplished at LiveCare, especially in how we've managed to transform diabetes care through our telehealth services," said Max Rockwell, CEO of LiveCare. "Our projected revenue growth and our plans to become a NASDAQ-listed company are just the beginning. We are dedicated to continuing our path of innovation, aiming to make a significant difference in the healthcare sector and in the lives of our patients."